Bristol-Myers Squibb Co (BMY)
53.54
+0.06 +0.11%
NYSE
Nov 20, 16:59
Delayed 2m
USD
View All Key Stats
BMY Key Stats
| Income Statement | |
| Revenue (TTM) | 22.04B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.89 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 1.432B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 71.04% |
| Profit Margin (Quarterly) | 33.40% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 87.39B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 3.981 |
| PE Ratio (TTM) | 60.16 |
| Price to Book Value | 6.407 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 1.055B |
| Return on Equity (TTM) | Upgrade |
View All BMY News
BMY News
-
WireHeadlineTime (ET)
-
Yahoo11/20 17:45
-
Yahoo11/20 13:10
-
Globe Newswire11/20 08:25
-
Yahoo11/20 08:12
-
Business Wire11/20 06:59
-
Yahoo11/19 09:49
-
Yahoo11/18 09:17
-
Yahoo11/16 14:52
-
Yahoo11/16 10:29
-
Yahoo11/16 08:35
View All Events
BMY Events
| Date | Type | Description |
|---|---|---|
| 02/05/2019 08:00 EST | Misc | Bristol-Myers Squibb Co Fourth Quarter Earnings Conference Call in 2018 |
| 02/05/2019 | Earnings | Bristol-Myers Squibb Co Fourth Quarter Earnings in 2018 Release |
| 10/25/2018 10:30 EDT | Misc | Bristol-Myers Squibb Co Third Quarter Earnings Conference Call in 2018 |
| 10/25/2018 | Earnings | Bristol-Myers Squibb Co Third Quarter Earnings in 2018 Release |
| 10/04/2018 | Dividends | Amount: 0.40, Declared Date: Sep 12 2018, Pay Date: Nov 01 2018 |
| 07/26/2018 10:30 EDT | Misc | Bristol-Myers Squibb Co Second Quarter Earnings Conference Call in 2018 |
| 07/26/2018 | Earnings | Bristol-Myers Squibb Co Second Quarter Earnings Results in 2018 |
| 07/05/2018 | Dividends | Amount: 0.40, Declared Date: Jun 14 2018, Pay Date: Aug 01 2018 |
| 05/01/2018 | Misc | Bristol-Myers Squibb Co Annual General Meeting in 2017 |
| 04/26/2018 10:30 EDT | Misc | Bristol-Myers Squibb Co First Quarter Earnings Conference Call in 2018 |
BMY Fundamentals
Income Statement View Statement
BMY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
BMY One Page Reports
- One Page Report Download
BMY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 53.54 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.bms.com
- Investor Relations URL: N/A
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Value
- Next Earnings Release: Feb. 05, 2019
- Last Earnings Release: Oct. 25, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Oct. 04, 2018
- Description: Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
BMY Excel Add-In Codes
- Name: =YCI("BMY","name")
- Description: =YCI("BMY","description")
- Sector: =YCI("BMY","sector")
- Industry: =YCI("BMY","industry")
- Est. Current Fiscal Year End: =YCI("BMY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other BMY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BMY Tweets Stocktwits
Advertisement
